Smith & Nephew PLC (SN) - Net Assets
Based on the latest financial reports, Smith & Nephew PLC (SN) has net assets worth GBX5.29 Billion GBX (≈ $643.75K USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX10.46 Billion ≈ $1.27 Million USD) and total liabilities (GBX5.17 Billion ≈ $629.03K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Smith & Nephew PLC (SN) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX5.29 Billion |
| % of Total Assets | 50.58% |
| Annual Growth Rate | 7.69% |
| 5-Year Change | -4.98% |
| 10-Year Change | 33.68% |
| Growth Volatility | 19.75 |
Smith & Nephew PLC - Net Assets Trend (1985–2025)
This chart illustrates how Smith & Nephew PLC's net assets have evolved over time, based on quarterly financial data. Also explore SN total assets for the complete picture of this company's asset base.
Annual Net Assets for Smith & Nephew PLC (1985–2025)
The table below shows the annual net assets of Smith & Nephew PLC from 1985 to 2025. For live valuation and market cap data, see market cap of Smith & Nephew PLC.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | GBX5.29 Billion ≈ $643.75K |
+0.49% |
| 2024-12-31 | GBX5.26 Billion ≈ $640.60K |
+0.92% |
| 2023-12-31 | GBX5.22 Billion ≈ $634.76K |
-0.80% |
| 2022-12-31 | GBX5.26 Billion ≈ $639.87K |
-5.55% |
| 2021-12-31 | GBX5.57 Billion ≈ $677.46K |
+5.47% |
| 2020-12-31 | GBX5.28 Billion ≈ $642.30K |
+2.68% |
| 2019-12-31 | GBX5.14 Billion ≈ $625.51K |
+5.48% |
| 2018-12-31 | GBX4.87 Billion ≈ $593.02K |
+4.95% |
| 2017-12-31 | GBX4.64 Billion ≈ $565.04K |
+17.33% |
| 2016-12-31 | GBX3.96 Billion ≈ $481.57K |
-0.20% |
| 2015-12-31 | GBX3.97 Billion ≈ $482.55K |
-1.83% |
| 2014-12-31 | GBX4.04 Billion ≈ $491.55K |
-0.17% |
| 2013-12-31 | GBX4.05 Billion ≈ $492.40K |
+4.20% |
| 2012-12-31 | GBX3.88 Billion ≈ $472.57K |
+21.87% |
| 2011-12-31 | GBX3.19 Billion ≈ $387.77K |
+14.93% |
| 2010-12-31 | GBX2.77 Billion ≈ $337.39K |
+27.26% |
| 2009-12-31 | GBX2.18 Billion ≈ $265.12K |
+28.25% |
| 2008-12-31 | GBX1.70 Billion ≈ $206.72K |
-6.44% |
| 2007-12-31 | GBX1.82 Billion ≈ $220.95K |
-16.47% |
| 2006-12-31 | GBX2.17 Billion ≈ $264.51K |
+51.50% |
| 2005-12-31 | GBX1.44 Billion ≈ $174.60K |
+6.57% |
| 2004-12-31 | GBX1.35 Billion ≈ $163.83K |
+17.67% |
| 2003-12-31 | GBX1.14 Billion ≈ $139.23K |
+37.33% |
| 2002-12-31 | GBX833.21 Million ≈ $101.38K |
+41.42% |
| 2001-12-31 | GBX589.18 Million ≈ $71.69K |
+47.35% |
| 2000-12-31 | GBX399.84 Million ≈ $48.65K |
-55.20% |
| 1999-12-31 | GBX892.49 Million ≈ $108.59K |
+10.75% |
| 1998-12-31 | GBX805.88 Million ≈ $98.05K |
+5.68% |
| 1997-12-31 | GBX762.58 Million ≈ $92.78K |
+2.27% |
| 1996-12-31 | GBX745.62 Million ≈ $90.72K |
+19.23% |
| 1995-12-31 | GBX625.35 Million ≈ $76.09K |
-10.30% |
| 1994-12-31 | GBX697.12 Million ≈ $84.82K |
+35.58% |
| 1993-12-31 | GBX514.17 Million ≈ $62.56K |
-6.40% |
| 1992-12-31 | GBX549.35 Million ≈ $66.84K |
+1.97% |
| 1991-12-31 | GBX538.71 Million ≈ $65.55K |
+3.40% |
| 1990-12-31 | GBX521.01 Million ≈ $63.39K |
+29.67% |
| 1989-12-31 | GBX401.80 Million ≈ $48.89K |
-7.36% |
| 1988-12-31 | GBX433.72 Million ≈ $52.77K |
-2.82% |
| 1987-12-31 | GBX446.29 Million ≈ $54.30K |
+43.34% |
| 1986-12-31 | GBX311.35 Million ≈ $37.88K |
+13.80% |
| 1985-12-31 | GBX273.58 Million ≈ $33.29K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Smith & Nephew PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4561.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | GBX5.32 Billion | 100.64% |
| Common Stock | GBX175.06 Million | 3.31% |
| Other Comprehensive Income | GBX20.01 Million | 0.38% |
| Total Equity | GBX5.29 Billion | 100.00% |
Smith & Nephew PLC Competitors by Market Cap
The table below lists competitors of Smith & Nephew PLC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Roto Pumps Limited
NSE:ROTO
|
$118.49 Million |
|
Forrester Research Inc
NASDAQ:FORR
|
$118.51 Million |
|
Treace Medical Concepts Inc
NASDAQ:TMCI
|
$118.52 Million |
|
Averlogic Technologies
TWO:6198
|
$118.53 Million |
|
Diamond Building Products Public Company Limited
BK:DRT
|
$118.45 Million |
|
Quantum Foods Holdings
JSE:QFH
|
$118.45 Million |
|
BEC World Public Company Limited
BK:BEC
|
$118.44 Million |
|
King Polytechnic Engineering Co Ltd
TWO:6122
|
$118.39 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Smith & Nephew PLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 5,265,000,000 to 5,290,926,775, a change of 25,926,775 (0.5%).
- Net income of 638,112,689 contributed positively to equity growth.
- Dividend payments of 336,923,499 reduced retained earnings.
- Share repurchases of 512,532,111 reduced equity.
- Other comprehensive income increased equity by 20,007,285.
- Other factors increased equity by 217,262,411.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX638.11 Million | +12.06% |
| Dividends Paid | GBX336.92 Million | -6.37% |
| Share Repurchases | GBX512.53 Million | -9.69% |
| Other Comprehensive Income | GBX20.01 Million | +0.38% |
| Other Changes | GBX217.26 Million | +4.11% |
| Total Change | GBX- | 0.49% |
Book Value vs Market Value Analysis
This analysis compares Smith & Nephew PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 189.23x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 3674.72x to 189.23x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-12-31 | GBX0.31 | GBX1147.00 | x |
| 1986-12-31 | GBX0.36 | GBX1147.00 | x |
| 1987-12-31 | GBX0.51 | GBX1147.00 | x |
| 1988-12-31 | GBX0.50 | GBX1147.00 | x |
| 1989-12-31 | GBX0.31 | GBX1147.00 | x |
| 1990-12-31 | GBX0.42 | GBX1147.00 | x |
| 1991-12-31 | GBX0.44 | GBX1147.00 | x |
| 1992-12-31 | GBX0.49 | GBX1147.00 | x |
| 1993-12-31 | GBX0.59 | GBX1147.00 | x |
| 1994-12-31 | GBX0.78 | GBX1147.00 | x |
| 1995-12-31 | GBX0.70 | GBX1147.00 | x |
| 1996-12-31 | GBX0.82 | GBX1147.00 | x |
| 1997-12-31 | GBX0.84 | GBX1147.00 | x |
| 1998-12-31 | GBX0.88 | GBX1147.00 | x |
| 1999-12-31 | GBX1.02 | GBX1147.00 | x |
| 2000-12-31 | GBX0.46 | GBX1147.00 | x |
| 2001-12-31 | GBX0.63 | GBX1147.00 | x |
| 2002-12-31 | GBX0.87 | GBX1147.00 | x |
| 2003-12-31 | GBX1.22 | GBX1147.00 | x |
| 2004-12-31 | GBX1.43 | GBX1147.00 | x |
| 2005-12-31 | GBX1.52 | GBX1147.00 | x |
| 2006-12-31 | GBX2.30 | GBX1147.00 | x |
| 2007-12-31 | GBX1.96 | GBX1147.00 | x |
| 2008-12-31 | GBX1.91 | GBX1147.00 | x |
| 2009-12-31 | GBX2.46 | GBX1147.00 | x |
| 2010-12-31 | GBX3.12 | GBX1147.00 | x |
| 2011-12-31 | GBX3.56 | GBX1147.00 | x |
| 2012-12-31 | GBX4.31 | GBX1147.00 | x |
| 2013-12-31 | GBX4.47 | GBX1147.00 | x |
| 2014-12-31 | GBX4.49 | GBX1147.00 | x |
| 2015-12-31 | GBX4.54 | GBX1147.00 | x |
| 2016-12-31 | GBX4.43 | GBX1147.00 | x |
| 2017-12-31 | GBX5.31 | GBX1147.00 | x |
| 2018-12-31 | GBX5.56 | GBX1147.00 | x |
| 2019-12-31 | GBX5.87 | GBX1147.00 | x |
| 2020-12-31 | GBX6.03 | GBX1147.00 | x |
| 2021-12-31 | GBX6.34 | GBX1147.00 | x |
| 2022-12-31 | GBX6.01 | GBX1147.00 | x |
| 2023-12-31 | GBX5.98 | GBX1147.00 | x |
| 2024-12-31 | GBX6.01 | GBX1147.00 | x |
| 2025-12-31 | GBX6.06 | GBX1147.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Smith & Nephew PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.06%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.14%
- • Asset Turnover: 0.60x
- • Equity Multiplier: 1.98x
- Recent ROE (12.06%) is below the historical average (22.07%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | 25.05% | 11.23% | 0.95x | 2.36x | GBX41.12 Million |
| 1986 | 28.72% | 12.58% | 0.80x | 2.86x | GBX58.20 Million |
| 1987 | 31.53% | 13.73% | 0.83x | 2.75x | GBX95.95 Million |
| 1988 | 33.53% | 13.48% | 0.85x | 2.94x | GBX101.92 Million |
| 1989 | 54.09% | 12.96% | 0.84x | 4.96x | GBX120.33 Million |
| 1990 | 39.09% | 10.17% | 0.92x | 4.19x | GBX106.52 Million |
| 1991 | 19.22% | 5.04% | 0.94x | 4.07x | GBX35.81 Million |
| 1992 | 36.47% | 11.99% | 0.97x | 3.14x | GBX113.16 Million |
| 1993 | 31.30% | 11.46% | 1.07x | 2.54x | GBX109.42 Million |
| 1994 | -12.10% | -5.59% | 1.14x | 1.90x | GBX-153.93 Million |
| 1995 | 27.89% | 10.99% | 1.25x | 2.04x | GBX111.81 Million |
| 1996 | 27.74% | 11.29% | 1.27x | 1.93x | GBX132.19 Million |
| 1997 | 24.66% | 10.85% | 1.21x | 1.87x | GBX111.75 Million |
| 1998 | 19.31% | 8.90% | 1.16x | 1.87x | GBX74.99 Million |
| 1999 | 19.01% | 9.36% | 1.14x | 1.78x | GBX80.34 Million |
| 2000 | 77.51% | 18.29% | 1.18x | 3.60x | GBX269.94 Million |
| 2001 | 32.03% | 11.98% | 0.99x | 2.71x | GBX129.81 Million |
| 2002 | 22.17% | 10.33% | 0.90x | 2.39x | GBX101.43 Million |
| 2003 | 23.11% | 12.56% | 0.95x | 1.94x | GBX150.04 Million |
| 2004 | 21.54% | 12.11% | 0.82x | 2.17x | GBX155.36 Million |
| 2005 | 23.21% | 13.05% | 0.86x | 2.07x | GBX189.50 Million |
| 2006 | 34.27% | 26.81% | 0.86x | 1.49x | GBX527.60 Million |
| 2007 | 17.40% | 9.38% | 0.76x | 2.46x | GBX134.40 Million |
| 2008 | 22.19% | 9.92% | 0.84x | 2.65x | GBX207.10 Million |
| 2009 | 21.66% | 12.51% | 0.83x | 2.09x | GBX254.10 Million |
| 2010 | 22.18% | 15.52% | 0.84x | 1.71x | GBX337.70 Million |
| 2011 | 18.26% | 13.63% | 0.90x | 1.49x | GBX263.30 Million |
| 2012 | 18.77% | 17.62% | 0.73x | 1.45x | GBX340.60 Million |
| 2013 | 13.74% | 12.78% | 0.75x | 1.44x | GBX151.30 Million |
| 2014 | 12.40% | 10.85% | 0.63x | 1.81x | GBX97.00 Million |
| 2015 | 10.34% | 8.85% | 0.65x | 1.81x | GBX13.40 Million |
| 2016 | 19.81% | 16.79% | 0.64x | 1.86x | GBX388.20 Million |
| 2017 | 16.52% | 16.10% | 0.61x | 1.69x | GBX302.60 Million |
| 2018 | 13.60% | 13.52% | 0.61x | 1.65x | GBX175.60 Million |
| 2019 | 11.67% | 11.68% | 0.55x | 1.81x | GBX85.90 Million |
| 2020 | 8.49% | 9.82% | 0.41x | 2.09x | GBX-79.90 Million |
| 2021 | 9.41% | 10.05% | 0.48x | 1.96x | GBX-32.80 Million |
| 2022 | 4.24% | 4.28% | 0.52x | 1.90x | GBX-302.90 Million |
| 2023 | 5.04% | 4.74% | 0.56x | 1.91x | GBX-258.70 Million |
| 2024 | 7.83% | 7.09% | 0.56x | 1.97x | GBX-114.50 Million |
| 2025 | 12.06% | 10.14% | 0.60x | 1.98x | GBX109.02 Million |
Industry Comparison
This section compares Smith & Nephew PLC's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $13,309,884
- Average return on equity (ROE) among peers: -24.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Smith & Nephew PLC (SN) | GBX5.29 Billion | 25.05% | 0.98x | $118.48 Million |
| AOTI Inc (AOTI) | $3.41 Million | 51.02% | 1.74x | $891.93K |
| Creo Medical Group PLC (CREO) | $1.37 Million | -123.43% | 0.18x | $633.60K |
| EKF Diagnostics Holdings Plc (EKF) | $-3.03 Million | 0.00% | 0.00x | $1.39 Million |
| Inspiration Healthcare Group PLC (IHC) | $1.65 Million | 0.00% | 0.38x | $322.92K |
| NIOX Group PLC (NIOX) | $81.90 Million | 19.66% | 0.20x | $3.41 Million |
| Polarean Imaging Plc (POLX) | $8.73 Million | -75.05% | 0.25x | $11.75K |
| Rua Life Sciences PLC (RUA) | $8.51 Million | -17.06% | 0.19x | $147.24K |
| Surgical Innovations Group plc (SUN) | $3.93 Million | -51.73% | 0.98x | $51.07K |
About Smith & Nephew PLC
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; t… Read more